Longitudinal metabolite profiling of <i>Streptococcus pneumoniae</i>-associated community-acquired pneumonia

Publication date

2024-03-05

Authors

den Hartog, I
Zwep, LB
Meulman, JJ
Hankemeier, T
van de Garde, Ewoudt M.W.ORCID 0000-0002-1334-2144ISNI 0000000391503086
van Hasselt, JGC

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Introduction Longitudinal biomarkers in patients with community-acquired pneumonia (CAP) may help in monitoring of disease progression and treatment response. The metabolic host response could be a potential source of such biomarkers since it closely associates with the current health status of the patient. Objectives In this study we performed longitudinal metabolite profiling in patients with CAP for a comprehensive range of metabolites to identify potential host response biomarkers. Methods Previously collected serum samples from CAP patients with confirmed Streptococcus pneumoniae infection (n = 25) were used. Samples were collected at multiple time points, up to 30 days after admission. A wide range of metabolites was measured, including amines, acylcarnitines, organic acids, and lipids. The associations between metabolites and C-reactive protein (CRP), procalcitonin, CURB disease severity score at admission, and total length of stay were evaluated. Results Distinct longitudinal profiles of metabolite profiles were identified, including cholesteryl esters, diacyl-phosphatidylethanolamine, diacylglycerols, lysophosphatidylcholines, sphingomyelin, and triglycerides. Positive correlations were found between CRP and phosphatidylcholine (34:1) (cor = 0.63) and negative correlations were found for CRP and nine lysophosphocholines (cor = − 0.57 to − 0.74). The CURB disease severity score was negatively associated with six metabolites, including acylcarnitines (tau = − 0.64 to − 0.58). Negative correlations were found between the length of stay and six triglycerides (TGs), especially TGs (60:3) and (58:2) (cor = − 0.63 and − 0.61). Conclusion The identified metabolites may provide insight into biological mechanisms underlying disease severity and may be of interest for exploration as potential treatment response monitoring biomarker.

Keywords

Community-acquired pneumonia, High-dimensional data, Longitudinal data, Metabolomics, Personalized medicine

Citation

den Hartog, I, Zwep, LB, Meulman, JJ, Hankemeier, T, van de Garde, EMW & van Hasselt, JGC 2024, 'Longitudinal metabolite profiling of <i >Streptococcus pneumoniae </i >-associated community-acquired pneumonia', Metabolomics, vol. 20, no. 2, 35. https://doi.org/10.1007/s11306-024-02091-5